Olfactory functions in Behçet’s disease: A review

Open access

Abstract

OBJECTIVES. We reviewed the relationship between olfactory functions and Behçet’s disease (BD).

MATERIAL AND METHODS. We searched Pubmed, Google, Google Scholar and Proquest Cebtral Database with the key words of “olfactory”, “functions”, “smell”, “nasal” and “Behçet’s disease”.

RESULTS. Behçet’s disease influences the nasal mucosa. Nasal mucosal inclusion causes mucosal ulcers, pain, burning, nasal obstruction, epistaxis, nasal itching and dysosmia. Nasal cartilage deformity is also reported. The higher rate of comorbid chronic rhinosinusitis (CRS) in BD patients may likewise be because of the complex mechanism of the disease inclining the host tissues to bacterial infections. Olfactory functions may decrease in BD. Odor identification may be lower in patients BD.

CONCLUSION. An olfactory dysfunction may be seen in patients with BD. BD patients should be evaluated for the involvement of the olfactory function and may require treatment because of a malfunction of the olfactory system that influences the quality of life. Neurological involvement associated with BD might play a more important role in causing olfactory dysfunction than mucosal involvement.

1. Alnaimat FA. Behcet Disease [Internet]. Medscape [update Dec 27, 2007]. Available from: http://emedicine.medscape.com/article/329099-overview#showall. Accessed February 17, 2017.

2. Alpsoy E. Behçet’s disease: A comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions. J Dermatol. 2016;43(6):620-32. DOI: 10.1111/1346-8138. Epub 2016 Apr 14.

3. Koné-Paut I, Geisler I, Wechsler B, Ozen S, Ozdogan H, Rozenbaum M, et al. Familial aggregation in Behçet’s disease: high frequency in siblings and parents of pediatric probands. J Pediatr. 1999;135(1):89-93.

4. de Menthon M, Lavalley MP, Maldini C, Guillevin L, Mahr A. HLA-B51/B5 and the risk of Behçet’s disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum. 2009; 61(10):1287-96. DOI: 10.1002/art.24642.

5. Veyseller B, Dogan R, Ozücer B, Aksoy F, Meric A, Su O, et al. Olfactory function and nasal manifestations of Behçet’s disease. Auris Nasus Larynx. 2014;41(2):185-9. DOI: 10.1016/j.anl.2013.07.014. Epub 2013 Oct 30.

6. Ozbay I, Kucur C, Temizturk F, Ozkan Y, Kahraman C, Oghan F. Assessment of nasal mucociliary activity in patients with Behçet’s disease. J Laryngol Otol. 2016;130(4):348-51. DOI: 10.1017/S0022215116000207. Epub 2016 Feb 4.

7. Krause I, Yankevich A, Fraser A, Rosner I, Mader R, Zisman D, et al. Prevalence and clinical aspects of Behcet’s disease in the north of Israel. Clin Rheumatol. 2007;26(4):555-60. Epub 2006 Aug 1.

8. Sakane T, Suzuki N, Takeno M. Innate and acquired immunity in Behçet’s disease. 8th International Congress on Behçet’s Disease. Reggio Emilia, Italy, 7-9 October 1998. Program and Abstracts: 56.

9. Emmi L, Brugnolo F, Salvati G, Marchione T. Immunopathological aspects of Behçet’s disease. Clin Exp Rheumatol. 1995;13(6):687-91.

10. Direskeneli H, Eksioglu-Demiralp E, Yavuz S, Ergun T, Shinnick T, Lehner T, et al. T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behçet’s disease. J Rheumatol. 2000;27(3):708-13.

11. Frassanito MA, Dammacco R, Cafforio P, Dammacco F. Th1 polarization of the immune response in Behçet’s disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum. 1999;42(9):1967-74.

12. Sugi-Ikai N, Nakazawa M, Nakamura S, Ohno S, Minami M. Increased frequencies of interleukin-2-and interferon-gamma-producing T cells in patients with active Behçet’s disease. Invest Ophthalmol Vis Sci. 1998;39(6):996-1004.

13. Hamzaoui K, Berraies A, Kaabachi W, Ammar J, Hamzaoui A. Pulmonary manifestations in Behcet disease: impaired natural killer cells activity. Multidiscip Respir Med.2013;8(1):29. DOI: 10.1186/2049-6958-8-29.

14. Dhong HJ, Kim HY, Ha BS. Histologic changes to olfactory epithelium in hypothyroid rats. Otolaryngol Head Neck Surg. 2003;129(1):24–32.

15. Akyol L, Günbey E, Karlı R, Önem S, Özgen M, Sayarlıoğlu M. Evaluation of olfactory function in Behçet’s disease. Eur J Rheumatol. 2016;3(4):153-6. DOI: 10.5152/eurjrheum.2016.017. Epub 2016 Dec 1.

16. Kern RC. Chronic sinusitis and anosmia: pathologic changes in the olfactory mucosa. Laryngoscope. 2000;110(7):1071–7.

17. Callahan CD, Hinkebein JH. Assessment of anosmia after traumatic brain injury: performance characteristics of the University of Pennsylvania Smell Identification Test. J Head Trauma Rehabil. 2002;17(3):251–6.

18. Hawkes C. Olfaction in neurodegenerative disorder. Mov Disord. 2003;18(4):364–72.

19. Klimek L, Moll B, Amedee RG, Mann WJ. Olfactory function after microscopic endonasal surgery in patients with nasal polyps. Am J Rhinol. 1997;11(4):251-5.

20. Landis BN, Scheibe M, Weber C, Berger R, Bramerson A, Bende M, et al. Chemosensory interaction: acquired olfactory impairment is associated with decreased taste function. J Neurol. 2010;257(8):1303-8. DOI: 10.1007/s00415-010-5513-8. Epub 2010 Mar 11.

21. Mattes RD. Physiologic responses to sensory stimulation by food: nutritional implications. J Am Diet Assoc. 1997;97(4):406-13.

22. Samuels MH. Psychiatric and cognitive manifestations of hypothyroidism. Curr Opin Endocrinol Diabetes Obes. 2014;21(5):377-83. DOI: 10.1097/MED.0000000000000089.

23. Ortega-Hernandez OD, Kivity S, Shoenfeld Y. Olfaction, psychiatric disorders and autoimmunity: is there a common genetic association? Autoimmunity. 2009;42(1):80-8. DOI: 10.1080/08916930802366140.

24. Shoenfeld N, Agmon-Levin N, Flitman-Katzevman I, Paran D, Katz BS, Kivity S, et al. The sense of smell in systemic lupus erythematosus. Arthritis Rheum. 2009;60(5):1484-7. DOI: 10.1002/art.24491.

25. O’Devaney K, Ferlito A, Devaney SL, Huner BC, Rinaldo A. Wegener’s granulomatosis of the head and neck. Ann Otol Rhinol Laryngol. 1996;107:439-45. DOI: 10.1177/000348949810700515.

26. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrouse B, Casassus P. Churg–Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore). 1999;78(1):26-37.

27. Robson AK, Burge SM, Millard PR. Nasal mucosal involvement in lupus erythematosus. Clin Otolaryngol Allied Sci. 1992;17(4):341-3.

28. Rasmussen N, Brofeldt S, Manthorpe R. Smell and nasal findings in patients with primary Sjögren’s syndrome. Scand J Rheumatol Suppl. 1986;61:142-5.

29. Weisman RA, Calcaterra TC. Head and neck manifestations of scleroderma. Ann Otol Rhinol Laryngol. 1978;87(3 Pt 1):332-9.

30. Rampelberg O, Gerard JM, Namias B, Gerard M. ENT manifestations of relapsing polychondritis. Acta Otorhinolaryngol Belg. 1997;51(2):73-7.

31. Peno IC, De las Heras Revilla V, Carbonell BP, Di Capua Sacoto D, Ferrer ME, Garcia-Cobos R, et al. Neurobehçet disease: clinical and demographic characteristics. Eur J Neurol. 2012;19(9):1224-7. DOI: 10.1111/j.1468-1331.2012.03706.x. Epub 2012 Apr 2.

32. Serdaroglu P. Behcet’s disease and the nervous system. J Neurol. 1998;245(4):197-205.

33. Oktem-Tanör O, Baykan-Kurt B, Gürvit IH, Akman-Demir G, Serdaroğlu P. Neuropsychological follow-up of 12 patients with neuro-Behçet disease. J Neurol. 1999;246(2):113-9.

34. Siva A, Altintas A, Saip S. Behcet’s syndrome and the nervous system. Curr Opin Neurol. 2004;17(3):347-57.

35. Okuyucu EE, Balci DD, Balci A, Duman T, Akcin E. Neurologic soft signs in Behcet disease. Neurologist. 2010;16(6):371-4. DOI: 10.1097/NRL.0b013e3181cf86c3.

36. Morales-Angulo C, Vergara Pastrana S, Obeso-Agüera S, Acle L, Gonzalez-Gay MA. Otorhinolaryngological manifestations in patients with Behçet disease. Acta Otorrinolaringol Esp. 2014;65(1):15-21. DOI: 10.1016/j.otorri.2013.06.007. Epub 2013 Oct 2.

37. Shahram F, Zarandy MM, Ibrahim A, Ziaie N, Saidi M, Nabaei B, et al. Nasal mucosal involvement in Behcet disease: a study of its incidence and characteristics in 400 patients. Ear Nose Throat J. 2010;89(1):30-3.

38. Morales-Angulo C, García-Zornoza R, Obeso-Agüera S, Calvo-Alén J, González-Gay MA. Ear, nose and throat manifestations of Wegener’s granulomatosis (granulomatosis with polyangiitis). Acta Otorrinolaringol Esp.2012;63(3):206-11. DOI: 10.1016/j.otorri.2011.12.002. Epub 2012 Mar 20.

39. Meric A, Dogan R, Su O, Eren SB, Tugrul S, Ozturan O. Correlation of Otorhinolaryngologic Symptoms with Physical Findings in Behçet’s Disease. B-ENT. 2015;11(1):31-7.

40. Rashid RM, Miller A, Scianna JM, Stankiewicz JA. Chronic rhinosinusitis and psoriasis: do mutually exclusive systemic Th1 and Th2 disease patterns exist? Acta Otolaryngol. 2007;127(7):780-3.

41. Verim A, Cebeci F, Baser E, Calim ÖF, Kadioğlu D, Kocagöz GD. Prevalence of chronic rhinosinusitis in the setting of Behçet disease. J Craniofac Surg. 2015;26(1):186-90. DOI: 10.1097/SCS.0000000000001202.

42. Direskeneli H. Autoimmunity vs autoinflammation in Behcet’s disease: do we oversimplify a complex disorder? Rheumatology. 2006;45(12):1461-5. Epub 2006 Sep 23.

43. Zachariae H. Prevalence of joint disease in patients with psoriasis: implications for therapy. Am J Clin Dermatol. 2003;4(7):441-7.

44. Kennedy JL, Borish L. Chronic sinusitis pathophysiology: The role of allergy. Am J Rhinol Allergy. 2013;27(5):367-71. DOI: 10.2500/ajra.2013.27.3906.

Journal Information

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 105 105 7
PDF Downloads 80 80 5